BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12740883)

  • 1. Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat.
    Jiang W; Jiang J; Xu D; Wang X; Qi S; Ouyang J; Ma A; Vu MD; Bilolo KK; Chen H
    Microsurgery; 2003; 23(2):117-22. PubMed ID: 12740883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
    Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
    Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
    Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
    Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H
    Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Baohuoside-1 aglycone and tacrolimus monotherapy and combination therapy on prevention of acute heart allograft rejection in the rat.
    Qi S; Zhao H; Ma A; Liu L; Wang X; Xu D; Lin G; Tamura K; Jiang H; Daloze P; Chen H
    Microsurgery; 2007; 27(4):268-70. PubMed ID: 17477431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin and tacrolimus differentially modulate acute graft-versus-host disease in rats after liver transplantation.
    Xu G; Wang L; Chen W; Xue F; Bai X; Liang L; Shen X; Zhang M; Xia D; Liang T
    Liver Transpl; 2010 Mar; 16(3):357-63. PubMed ID: 20209637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
    Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
    J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts.
    Vu MD; Qi S; Wang X; Jiang W; Ma A; Xu D; Bekersky I; Fitzsimmons WE; Wu J; Chen H
    Transplantation; 2003 May; 75(9):1455-9. PubMed ID: 12792496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat.
    Vu MD; Qi S; Xu D; Wu J; Fitzsimmons WE; Sehgal SN; Dumont L; Busque S; Daloze P; Chen H
    Transplantation; 1997 Dec; 64(12):1853-6. PubMed ID: 9422432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
    Tu Y; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection.
    Aharoni R; Yussim A; Sela M; Arnon R
    Int Immunopharmacol; 2005 Jan; 5(1):23-32. PubMed ID: 15589456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-mediated prolongation of rat cardiac allograft survival is enhanced by beta1 integrin very late antigen-4 blockade.
    Vu MD; Qi S; Sehgal SN; Chen H; Kennedy JD
    Transplant Proc; 2005; 37(1):162-3. PubMed ID: 15808581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
    Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.
    Ugurlu MM; Griffin MD; Tazelaar HD; McGregor CG
    Transplantation; 2003 Aug; 76(3):489-95. PubMed ID: 12923433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of immunosuppressive therapy after experimental small bowel transplantation in rats.
    Pech T; Fujishiro J; Finger T; von Websky M; Stoffels B; Wehner S; Abu-Elmagd K; Kalff JC; Schaefer N
    Transpl Immunol; 2011 Sep; 25(2-3):112-8. PubMed ID: 21820512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of acute rejection after skin or cardiac transplantation by administration of donor antigens in the rat.
    Shirouzu Y; Hikida S; Tanigawa H; Shirouzu K
    Surg Today; 2004; 34(4):341-8. PubMed ID: 15052450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival.
    Fang YH; Joo DJ; Lim BJ; Huh KH; Kim MS; Suh H; Kim YS
    J Surg Res; 2011 Nov; 171(1):e133-7. PubMed ID: 21816421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506.
    Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Takemura S; Minamiyama Y; Ikeda K; Hirohashi K; Suehiro S
    Transplant Proc; 2005; 37(1):126-9. PubMed ID: 15808570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction with T-cell receptor antibody leads to long-term laryngeal allograft function.
    Knott PD; Dan O; Strome M
    Am J Otolaryngol; 2008; 29(6):398-402. PubMed ID: 19144301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.